Overall Fundamental outlook

* MEDANTA makes the list of companies with the best technicals at present.

Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

Global Health Limited engages in the provision of healthcare services in India. The company primarily offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, musculoskeletal disorders and orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, plastic, aesthetic and reconstructive surgery, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, ayurveda, and dietetics and nutrition. It also offers lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, blood bank and e-ICU services, and health plans, as well as operates pharmacies. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in New Delhi, India.

Revenue projections:

Revenue projections for MEDANTA
Revenue projections for MEDANTA

Investors may react cautiously to news that Global Health Limited's revenues are forecasted to be lower than last year's. Such declines are likely to have a negative effect on the company's bottom line, which can lead to concerns about profitability and hinder investor confidence in the company's future performance.

Financial Ratios:

currentRatio 2.478000
forwardPE 40.798515
debtToEquity 21.188000
earningsGrowth -0.204000
revenueGrowth 0.128000
grossMargins 0.538440
operatingMargins 0.188390
trailingEps 17.960000
forwardEps 23.410000

MEDANTA's current ratio of 2.478, indicating that the company can meet its short-term debt obligations with ease. This high liquidity level is a positive sign, as MEDANTA has enough cash and current assets to handle its immediate liabilities comfortably.
MEDANTA's low Debt-to-Equity ratio reflects the company's conservative use of debt. This shows that it isn't over-leveraged, reducing financial risk and indicating a stable financial structure, which is a positive signal for investors concerned about excessive debt burdens.
Global Health Limited's low earnings and revenue growth suggest shrinking profits are likely. This could reflect broader financial struggles, signaling that the company might face difficulties in sustaining its profitability.
MEDANTA's negative gross and operating margins suggest the company is not generating profit from either its production process or day-to-day operations. This could signal cost overruns or difficulties in maintaining revenue levels.
MEDANTA's forward EPS is higher than its trailing EPS, suggesting the company is expected to see an increase in profitability this year. This points to positive growth, indicating that MEDANTA is projected to improve its financial performance compared to the previous year.

Price projections:

Price projections for MEDANTA
Price projections for MEDANTA

Price projections for MEDANTA have been steadily revised downward over time, indicating growing concerns about the company's future performance. This downward trend reflects reduced optimism among analysts regarding MEDANTA's ability to meet previous expectations.

Recommendation changes over time:

Recommendations trend for MEDANTA
Recommendations trend for MEDANTA


With analysts showing a buy bias for MEDANTA, investors may be more inclined to see the stock as an attractive investment. The favorable outlook could spur increased interest, positioning MEDANTA as a safe and profitable place for investors to allocate their funds and seek growth.